Neuroimaging plays an ever evolving role in the diagnosis, treatment planning, and post-
therapy assessment of brain tumors. This review provides an overview of current magnetic …

Radiographic endpoints including response and progression are important for the
evaluation of new glioblastoma therapies. The current RANO criteria was developed to …

Summary Background The Response Assessment in Neuro-Oncology (RANO) criteria and
requirements for a uniform protocol have been introduced to standardise assessment of MRI …

Glioblastoma is the most common aggressive adult brain tumor. Numerous studies have
reported results from either private institutional data or publicly available datasets. However …

Background Treatment options for recurrent glioblastoma are scarce, with second-line
chemotherapy showing only modest activity against the tumour. Despite the absence of well …

Background Longitudinal measurement of glioma burden with MRI is the basis for treatment
response assessment. In this study, we developed a deep learning algorithm that …

PURPOSE The Response Assessment in Neuro-Oncology (RANO) criteria are widely used
in high-grade glioma clinical trials. We compared the RANO criteria with updated …

Gliomas possess complex and heterogeneous vasculatures with abnormal hemodynamics.
Despite considerable advances in diagnostic and therapeutic techniques for improving …

Background The study goal was to determine whether changes in relative cerebral blood
volume (rCBV) derived from dynamic susceptibility contrast (DSC) MRI are predictive of …

Magnetic resonance imaging is integral to the care of patients with high-grade gliomas.
Anatomic detail can be acquired with conventional structural imaging, but newer …